Trend
Address insured-book cost, led by cardiometabolic conditions and GLP-1 spend
Commercial & ASO
Dario engagement is a leading indicator of impact, while clinical outcomes validate health improvements and drive downstream cost savings.


A1c, blood pressure and weight can move before the full claims picture matures. Dario uses these clinical measures as leading indicators while claims analysis validates downstream economic performance.
See the Commercial / ASO opportunity.
Talk with Dario(1) Sanofi, JMIR 2025. (2) Dario Clinical Data Overview, July 2026, pp. 21, 22, 26. (3) Wilson L, et al. J Med Internet Res. 2025;27:e67320. doi:10.2196/67320; Dario Clinical Data Overview, July 2026, pp. 22, 26.